Bafiertam is a new oral Disease-Modifying Therapy for relapsing forms of MS.
The active ingredient in Bafiertam is Monomethyl Fumarate or MMF.
It has the same active ingredient as other fumarates (Tecfidera and Vumerity).
Bafiertam has the same established efficacy and well understood safety profile as Tecfidera. Bafiertam reduces the number of relapses, delays the disability progression of MS, and slows the development of brain lesions in MS Patients.
Bafiertam is different from other fumarates, because it does not require metabolic conversion in the stomach to become active. It is directly active MMF.
One of the advantages of not having to be converted in the stomach, is that Bafiertam can be taken with or without food and there are no dietary restrictions.
For patients starting on Bafiertam, Banner Life Sciences can offer a comprehensive Patient Support Program for all patients regardless of insurance coverage. This includes Commercial and Government insurance, as well as under and non-insured patients with MS.
For more information, please visit Patient Homepage | BAFIERTAM® (monomethyl fumarate)
or call our patient support at 1-855-3BANNER